The effect of short-term overfeeding on serum lipids in healthy humans

Obesity

Volumn 21, Issue 12, 2013, Pages

  Heilbronn, Leonie K ^a   Coster, Adelle C F ^b,c   Campbell, Lesley V ^b,c   Greenfield, Jerry R ^b,c   Lange, Kylie ^a   Christopher, Michael J ^d   Meikle, Peter J ^d   Samocha Bonet, Dorit ^b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLHOSPHATIDYLETHANOLAMINE; C REACTIVE PROTEIN; CERAMIDE; DIACYLGLYCEROL; ETHANOLAMINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LYSOALKYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PLASMALOGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MASS SPECTROMETRY; OVERNUTRITION; WEIGHT GAIN; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CERAMIDES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; DIGLYCERIDES; ENERGY INTAKE; F2-ISOPROSTANES; FATTY ACIDS, NONESTERIFIED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MOTOR ACTIVITY; OVERNUTRITION; PLASMALOGENS; TRIGLYCERIDES; WEIGHT GAIN;

EID: 84889690537     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20508     Document Type: Article

References (40)

1. Kotronen A, Seppanen-Laakso T, Westerbacka J, et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity 2010; 18: 937-944.
2. Meikle PJ, Christopher MJ,. Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Curr Opin Lipidol 2011; 22: 210-215.
3. Brons C, Jacobsen S, Nilsson E, et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 2010; 95: 3048-3056.
4. Samocha-Bonet D, Campbell LV, Viardot A, et al. A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia 2010; 53: 1700-1708.
5. Karpe F, Dickmann JR, Frayn KN,. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011; 60: 2441-2449.
6. Brons C, Jensen CB, Storgaard H, et al. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 2009; 587: 2387-2397.
7. Ravussin E, Schutz Y, Acheson KJ, et al. Short-term, mixed-diet overfeeding in man: no evidence for "luxuskonsumption". Am J Physiol 1985; 249: E470-E477.
8. Cornier MA, Bergman BC, Bessesen DH,. The effects of short-term overfeeding on insulin action in lean and reduced-obese individuals. Metabolism 2006; 55: 1207-1214.
9. Samocha-Bonet D, Campbell LV, Mori TA, et al. Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans. PLoS One 2012; 7: e36320.
10. Graessler J, Schwudke D, Schwarz PE, et al. Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 2009; 4: e6261.
11. Haus JM, Kashyap SR, Kasumov T, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009; 58: 337-343.
12. Pietilainen KH, Sysi-Aho M, Rissanen A, et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS One 2007; 2: e218.
13. Barber MN, Risis S, Yang C, et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012; 7: e41456.
14. Mittelstrass K, Ried JS, Yu Z, et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 2011; 7: e1002215.
15. Kien CL, Bunn JY, Poynter ME, et al. A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes 2013; 62: 1054-1063.
16. Schwab U, Seppanen-Laakso T, Yetukuri L, et al. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-the GENOBIN study. PLoS One 2008; 3: e2630.
17. Huang H, Kasumov T, Gatmaitan P, et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity 2011; 19: 2235-2240.
18. Wiesner P, Leidl K, Boettcher A, et al. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 2009; 50: 574-585.
19. Tam CS, Viardot A, Clement K, et al. Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes 2010; 59: 2164-2170.
20. Meikle PJ, Wong G, Tsorotes D, et al. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2011; 31: 2723-2732.
21. Borg ML, Andrews ZB, Duh EJ, et al. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 2011; 60: 1458-1466.
22. Boslem E, MacIntosh G, Preston AM, et al. A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 2011; 435: 267-276.
23. Drew BG, Rye KA, Duffy SJ, et al. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol 2012; 8: 237-245.
24. Maeba R, Ueta N,. Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 2003; 44: 164-171.
25. Hoofnagle AN, Vaisar T, Mitra P, et al. HDL lipids and insulin resistance. Curr Diab Rep 2010; 10: 78-86.
26. Yetukuri L, Soderlund S, Koivuniemi A, et al. Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res 2010; 51: 2341-2351.
27. Kumashiro N, Erion DM, Zhang D, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011; 108: 16381-16385.
28. Magkos F, Su X, Bradley D, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 2012; 142: 1444-1446.
29. Zhong L, Chen JJ, Chen J, et al. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis 2009; 10: 315-320.
30. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab 2008; 93: 2702-2708.
31. Hannun YA, Obeid LM,. Many ceramides. J Biol Chem 2011; 286: 27855-27862.
32. Bikman BT, Summers SA,. Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 2011; 121: 4222-4230.
33. Chavez JA, Summers SA,. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim Biophys Acta 2010; 1801: 252-265.
34. Boon J, Hoy AJ, Stark R, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 2013; 62: 401-410.
35. Schissel SL, Tweedie-Hardman J, Rapp JH, et al. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455-1464.
36. Schmitz G, Ruebsaamen K,. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010; 208: 10-18.
37. Pietilainen KH, Naukkarinen J, Rissanen A, et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 2008; 5: e51.
38. Rabini RA, Galassi R, Fumelli P, et al. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 1994; 43: 915-919.
39. Zhao X, Fritsche J, Wang J, et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 2010; 6: 362-374.
40. Welch EJ, Naikawadi RP, Li Z, et al. Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation. Mol Pharmacol 2009; 75: 227-234.